1NA develops its NanoLoom single-molecule imaging platform to generate high-throughput data on DNA–protein interactions, enabling drug screening focused on mitochondrial dysfunction and replication machinery. The company collaborates with partners on validation projects and was recognized with a 2025 CES Innovation Award as one of the Netherlands’ most innovative startups.